细胞生物学、分子生物学和免疫学等学科的飞速发展 ,以及新的实验体系和新的技术方法的不断涌现 ,促进了肿瘤递呈性免疫治疗的日新月异 ,树突状细胞作为体内功能最强的抗原递呈细胞在以 T细胞识别肿瘤抗原为核心的肿瘤生物治疗研究中展现了良好的应用前景。本文通过对树突状细胞在肿瘤疫苗中设计策略的综述 ,有助于更加准确地看待当今的肿瘤生物治疗。 The rapid development of such disciplines as cell biology, molecular biology and immunology, as well as the continuous emergence of new experimental systems and new technology methods, has promoted the rapid development of tumor-directed immunotherapy, with dendritic cells as the most powerful in vivo function. The antigen-presenting cells have a good application prospect in the research of tumor biological therapy with the T cell recognition tumor antigen as the core. This review of the design strategies for dendritic cells in cancer vaccines will help to more accurately view today’s cancer biotherapy.